|
SLC35B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.40870000009797E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.98099999999735E-05 |
| Normal-vs-Stage2 |
1.141580E-01 |
| Normal-vs-Stage3 |
1.827500E-02 |
| Normal-vs-Stage4 |
1.975010E-01 |
| Stage1-vs-Stage2 |
5.353600E-01 |
| Stage1-vs-Stage3 |
6.357800E-01 |
| Stage1-vs-Stage4 |
8.211600E-01 |
| Stage2-vs-Stage3 |
4.110400E-01 |
| Stage2-vs-Stage4 |
8.197600E-01 |
| Stage3-vs-Stage4 |
6.600600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59010000003279E-07 |
| Normal-vs-AfricanAmerican |
1.933560E-02 |
| Normal-vs-Asian |
3.628200E-01 |
| Caucasian-vs-AfricanAmerican |
4.144300E-02 |
| Caucasian-vs-Asian |
9.052000E-01 |
| AfricanAmerican-vs-Asian |
5.599600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58680000000345E-05 |
| Normal-vs-Female |
3.82600000004008E-06 |
| Male-vs-Female |
2.441900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.533630E-02 |
| Normal-vs-Extreme_Weight |
1.575130E-04 |
| Normal-vs-Obese |
1.050300E-02 |
| Normal-vs-Extreme_Obese |
5.585400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.246400E-01 |
| Normal_Weight-vs-Obese |
7.007000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.592600E-01 |
| Extreme_Weight-vs-Obese |
4.613600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.106000E-01 |
| Obese-vs-Extreme_Obese |
6.648000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.834080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.59439999980471E-07 |
| Normal-vs-Age(61-80Yrs) |
2.503900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.654400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.157800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.072200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.923600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.229760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.186100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.758600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.45349999994771E-07 |
| Normal-VS-Type2 PRCC |
5.030300E-04 |
| Normal-VS-KIRP CIMP |
6.400200E-01 |
| Normal-VS-Unclassified PRCC |
1.775850E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.394200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.303800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.342600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.804400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.391600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.621000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.416600E-03 |
| Normal-vs-N1 |
9.592400E-02 |
| Normal-vs-N2 |
1.133220E-01 |
| N0-vs-N1 |
9.879800E-01 |
| N0-vs-N2 |
1.118380E-02 |
| N1-vs-N2 |
4.662000E-02 |
|
|
